Investigators note that although the overall cost for implementing next-generation sequencing (NGS) testing would be more than implementing current polymerase chain reaction (PCR)–based testing, the ...
Addition of next generation sequencing research panels, bioinformatics, positions IDT to become a leading oncology research solutions provider “The acquisition of the NGS research assays aligns with ...
Circulogene today announced the national launch of OncoGenDx, an innovative tissue-based comprehensive genomic profiling (CGP ...
IDT’s partnership with Hamilton marks a global agreement to develop automation scripts for xGen™ and Archer™ NGS products ...
Illumina has launched Protein Prep, an assay that measures up to 9,500 unique human protein targets using next-generation sequencing (NGS).
Precision medicine is key to developing more effective and less toxic treatments, representing the present and future of oncology research. This approach offers significant promise for incremental ...
Comparative genomic landscape of patients with lung cancer with high-load versus low-load Epstein-Barr virus infection. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This ...
Employing Liquid-Handling Automation For Faster and More Reliable Results In the next three years, the number of next-generation sequencing (NGS) samples processed will more than double. The NGS ...
Pan-Cancer Interrogation of MUTYH Variants Reveals Biallelic Inactivation and Defective Base Excision Repair Across a Spectrum of Solid Tumors Clinically relevant actionable mutations were identified ...
HAYWARD, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Predicine, Inc., a leading molecular insights company, today announced the submission of the first module of its premarket approval (PMA) ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback